Segall Bryant & Hamill LLC Sells 11,101 Shares of SIGA Technologies, Inc. (NASDAQ:SIGA)

Segall Bryant & Hamill LLC lowered its holdings in SIGA Technologies, Inc. (NASDAQ:SIGA) by 3.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 314,035 shares of the company’s stock after selling 11,101 shares during the period. Segall Bryant & Hamill LLC owned approximately 0.44% of SIGA Technologies worth $1,887,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Intech Investment Management LLC bought a new stake in SIGA Technologies during the 3rd quarter valued at $120,000. Charles Schwab Investment Management Inc. grew its position in shares of SIGA Technologies by 5.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 507,262 shares of the company’s stock valued at $3,424,000 after purchasing an additional 24,101 shares in the last quarter. Algert Global LLC bought a new stake in shares of SIGA Technologies during the 3rd quarter valued at $464,000. Larson Financial Group LLC bought a new stake in shares of SIGA Technologies during the 3rd quarter valued at $30,000. Finally, Freedom Investment Management Inc. purchased a new stake in SIGA Technologies during the 3rd quarter worth about $157,000. 55.40% of the stock is currently owned by hedge funds and other institutional investors.

SIGA Technologies Stock Down 0.4 %

SIGA stock opened at $5.55 on Friday. The stock has a 50-day simple moving average of $5.86 and a two-hundred day simple moving average of $6.47. SIGA Technologies, Inc. has a twelve month low of $5.16 and a twelve month high of $12.83. The firm has a market capitalization of $396.48 million, a PE ratio of 4.63 and a beta of 0.98.

SIGA Technologies (NASDAQ:SIGA) last posted its earnings results on Tuesday, March 11th. The company reported $0.63 earnings per share for the quarter. SIGA Technologies had a net margin of 49.33% and a return on equity of 49.06%. The business had revenue of $81.40 million for the quarter. On average, equities research analysts anticipate that SIGA Technologies, Inc. will post 1.04 EPS for the current fiscal year.

SIGA Technologies Company Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.